Oral colon-release parnaparin sodium tablets are safe and effective as an adjunctive therapy to aminosalicylates in patients with ulcerative colitis, according to a recently published clinical trial.
All were randomized, double-blinded, placebo-controlled trials assessing treatments for biopsy-proven, clinically-active collagenous colitis. The first of these included four patients who received ...